Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alberts D. S., Salmon S. E., Chen H. S., Moon T. E., Young L., Surwit E. A. Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol. 1981;6(3):253–264. doi: 10.1007/BF00256978. [DOI] [PubMed] [Google Scholar]
- Fish R. G., Shelley M. D., Griffiths H. Total body clearance and platinum accumulation in patients treated with cis-dichlorodiammine platinum (II) Ther Drug Monit. 1984;6(2):251–252. doi: 10.1097/00007691-198406000-00021. [DOI] [PubMed] [Google Scholar]
- Gershenson D. M., Wharton J. T., Herson J., Edwards C. L., Rutledge F. N. Single-agent cis-platinum therapy for advanced ovarian cancer. Obstet Gynecol. 1981 Oct;58(4):487–496. [PubMed] [Google Scholar]
- Holdener E. E., Park C. H., Belt R. J., Stephens R. L., Hoogstraten B. Effect of mannitol and plasma on the cytotoxicity of cisplatin. Eur J Cancer Clin Oncol. 1983 Apr;19(4):515–518. doi: 10.1016/0277-5379(83)90115-3. [DOI] [PubMed] [Google Scholar]
- Vermorken J. B., van der Vijgh W. J., Klein I., Hart A. A., Gall H. E., Pinedo H. M. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep. 1984 Mar;68(3):505–513. [PubMed] [Google Scholar]
- Von Hoff D. D. "Send this patient's tumor for culture and sensitivity". N Engl J Med. 1983 Jan 20;308(3):154–155. doi: 10.1056/NEJM198301203080310. [DOI] [PubMed] [Google Scholar]
- Von Hoff D. D., Weisenthal L. In vitro methods to predict for patient response to chemotherapy. Adv Pharmacol Chemother. 1980;17:133–156. doi: 10.1016/s1054-3589(08)60009-5. [DOI] [PubMed] [Google Scholar]
- Wilson A. P., Neal F. E. In vitro sensitivity of human ovarian tumours to chemotherapeutic agents. Br J Cancer. 1981 Aug;44(2):189–200. doi: 10.1038/bjc.1981.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
